document type sequence filename description exhibit text html head title title head body style font time roman time serif style margin nbsp style font bold time roman time serif margin text align right exhibit style font time roman time serif margin text indent nbsp style font bold time roman time serif margin text align center font style text transform uppercase license agreement font style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent this license agreement this ldquo agreement rdquo this ldquo license agreement rdquo effective january ldquo effective date rdquo among regenerx biopharmaceuticals company organized existing under state delaware with office shady grove road suite rockville maryland hereinafter ldquo licensor rdquo regentree with office shady grove road suite rockville maryland hereinafter ldquo licensee rdquo each ldquo party rdquo collectively ldquo party rdquo style font time roman time serif margin text align center font style font weight normal font variant small nbsp font style font time roman time serif margin text align center font style font weight normal font variant small recital font style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent whereas licensor engaged business developing biopharmaceutical product including clinical clinical development future commercialization product defined herein style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent whereas licensee engaged been organized engaged business developing marketing manufacturing distributing biopharmaceutical product pursuant joint venture between licensor parent defined herein purpose developing commercializing product field territory which joint venture governed term condition agreement defined herein style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent whereas pursuant term agreement licensor agreed grant licensee wish obtain term condition forth herein right develop manufacture commercialize product field territory each such term defined herein style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent therefore consideration premise other good valuable consideration receipt sufficiency which hereby acknowledged party agree follows style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent font style font time roman time serif section font definition style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent used this agreement following capitalized term shall have following meaning style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo affiliate rdquo shall mean with respect person person that control controlled under common control with such first person purpose this definition only ldquo control rdquo mean posse directly indirectly power direct management policy person whether through ownership voting security contract relating voting right corporate governance directly indirectly least fifty percent outstanding voting security other ownership interest such person avoidance doubt licensee parent affiliate each other licensor affiliate licensee style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo agreement rdquo shall have meaning given such term preamble style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo rdquo shall mean beta form active ingredient utilized component product style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo business rdquo shall mean font style background color white year other than saturday sunday which national banking institution york maryland open public conducting business required authorized closed font style font time roman time serif margin nbsp style font time roman time serif margin ldquo challenge rdquo shall have meaning given such term section nbsp style font time roman time serif margin nbsp style font time roman time serif margin information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin ldquo change control rdquo shall mean with respect party occurrence following style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent consolidation merger recapitalization reorganization party with into third party other corporate reorganization involving third party ldquo merger rdquo long stockholder such party immediately prior merger than fifty percent surviving entity rsquo voting power immediately after merger style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent change beneficial ownership more than fifty percent voting security party whether single transaction series related transaction where immediately after giving effect such change legal beneficial owner more than fifty percent voting security such party third party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent sale transfer assignment other similar disposition third party substantially party rsquo asset which this agreement relates series related transaction style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo rdquo shall mean chemistry manufacturing control that critical element drug development process increase complexity development process matures includes manufacturing bulk drug substance final drug product establishing specification release criterion stability program analytical method style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo commercialization plan rdquo shall have meaning given such term section nbsp style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent ldquo commercially diligent effort rdquo shall mean with respect development commercialization licensee least product level effort resource generally used similarly situated pharmaceutical company developing marketing compound product throughout territory including internally developed acquired licensed compound product with similar commercial potential similar stage their lifecycle assuming continuing development such product style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo confidential information rdquo shall mean information data result invention trade secret technique material composition matter type kind including without limitation know other scientific clinical clinical regulatory manufacturing marketing personnel financial legal commercial information data whether communicated writing orally other method that party treat identifies confidential each case disclosed party other party under this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo control rdquo ldquo control rdquo ldquo controlled rdquo shall mean with respect particular item information intellectual property right that applicable party affiliate such party owns license such item right ability grant other party access license sublicense applicable under such item right provided herein without violating term agreement other arrangement with third party existing effective date thereafter style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo development plan rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo disclosing party rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo distributor rdquo shall mean third party appointed licensee distribute market sell product purchased from licensee affiliate regardless whether such third party right obligation provide packaging labeling service with respect such product style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence option newsection value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent ldquo syndrome rdquo mean multifactorial disease tear ocular surface that result symptom discomfort visual disturbance tear film instability with potential damage ocular surface commonly accompanied increased osmolarity tear film inflammation ocular surface style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo effective date rdquo shall have meaning given such term preamble style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo rdquo shall mean united state food drug administration successor governmental agency performing similar function style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo field rdquo shall mean treatment human ophthalmic disease condition territory using beta formulation delivered topically whether form prescription drug over counter drug medical device otherwise provided however that ldquo field rdquo shall include product incorporated into form type cosmetic food product style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent ldquo first commercial sale rdquo shall mean initial sale product behalf licensee affiliate sublicensees distributor exchange cash some equivalent which value assigned purpose determining sale territory following regulatory approval product territory clarity first commercial sale shall include transfer product below cost behalf licensee affiliate sublicensees distributor connection with compassionate emergency treatment inds like authorized corresponding governmental authority territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo gaap rdquo shall mean case licensor generally accepted accounting principle recognized united state case licensee generally accepted accounting principle recognized united state style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo generic branded generic rdquo shall mean drug product containing same active ingredient product subject regulation government country where they dispensed comparable brand reference listed drug product dosage form strength route administration quality performance characteristic intended style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent ldquo rdquo shall mean then current good clinical practice defined regulation sect sect international conference harmonization ldquo good clinical practice consolidated guidance rdquo successor regulation official guidance document issued governmental authority style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent ldquo rdquo shall mean then current good laboratory practice standard defined pursuant part successor regulation official guidance document issued governmental authority style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo rdquo shall mean then current good manufacturing practice defined pursuant sect sect successor regulation official guidance document issued governmental authority style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo governmental action rdquo shall have meaning given such term section style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent ldquo governmental authority rdquo shall mean national federal provincial state municipal other governmental body jurisdiction territory elsewhere nbsp international multi lateral body subdivision ministry department secretariat bureau agency commission board instrumentality authority foregoing government body quasi governmental private body exercising regulatory expropriation taxing authority under foregoing government body international multi lateral multi national judicial quasi judicial arbitration administrative court grand jury tribunal commission board panel each case having jurisdiction over united state jurisdiction within territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo rule rdquo shall have meaning given such term section style font time roman time serif margin nbsp style font time roman time serif margin ldquo rdquo shall mean international conference harmonization style font time roman time serif margin nbsp style font time roman time serif margin text indent ldquo rdquo shall mean investigational drug application filed with equivalent jurisdiction territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo indemnified party rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo indemnifying party rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo intellectual property rdquo shall mean invention patent patent right utility model copyright trade secret trademark service mark know technical information other intellectual property right style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo invention rdquo shall mean process method composition matter article manufacture discovery finding invention whether patentable style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo joint development committee rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo joint invention rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo agreement rdquo shall mean that certain joint venture agreement entered into date hereof between licensor parent style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo know rdquo shall mean tangible intangible technique technology practice trade secret method knowledge know skill experience test data result including pharmacological toxicological clinical test data result analytical quality control data result description software algorithm compound composition matter physical biological chemical material style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo rdquo shall mean constitution treaty statute code ordinance guidance order decree rule regulation municipal governmental authority whether domestic foreign international otherwise agreed writing between party judgment order writ injunction decision ruling decree award governmental authority policy practice guideline governmental authority style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent ldquo licensed know rdquo shall mean know owned controlled licensor that exists effective date time thereafter during term each case that necessary useful development registration manufacture promotion marketing distribution sale product field territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent ldquo licensed patent rdquo shall mean patent owned controlled licensor effective date listed exhibit nbsp hereto extent that such patent disclose claim product well future patent owned controlled licensor affiliate during term extent that such future patent disclose claim product style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo licensee rdquo shall have meaning given such term preamble style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo licensee invention rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo licensee product data rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo licensor rdquo shall have meaning given such term preamble style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo licensor invention rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo loss rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo marketing approval rdquo shall mean approval license registration authorization regulatory authority jurisdiction territory necessary manufacture storage marketing importation sale product such jurisdiction style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo marketing year rdquo shall mean period commencing date first marketing approval territory ending december same year thereafter duration this agreement each subsequent marketing year will correspond calendar year period from january december style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo rdquo shall mean drug application submitted drug sponsor pursuant section food drug cosmetic related regulation promulgated thereunder vehicle through which drug sponsor formally proposes that approve pharmaceutical product sale marketing style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo sale rdquo shall mean gross receipt sale made licensee affiliate sublicensees distributor article substance containing product other independent buyer bona fide rsquo length transaction following deduction with respect such sale extent applicable product extent actually allowed taken quantity cash discount actually allowed taken extent customary custom duty excise directly related sale product actually paid amount allowed reason rejection return good third party rebate related sale product import value added other similar sale related sale product extent accordance with gaap consistently applied across product licensee notwithstanding foregoing sale shall include shall deemed zero with respect product used licensee affiliate sublicensees their internal product provided behalf licensee affiliate sublicensees purpose resale within territory provided such final resale included sale deduction shall made commission paid individual whether with independent sale agency regularly employed licensee affiliate sublicensees distributor payroll cost collection sale made other than rsquo length transaction value sale attributed such transaction shall that which would have been received rsquo length transaction based sale like quantity quality product about time such transaction style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent ldquo neurotrophic keratopathy rdquo ldquo rdquo shall mean rare degenerative corneal disease caused impairment trigeminal corneal innervation leading decrease absence corneal sensation style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo asia license agreement rdquo shall mean that certain license agreement dated march between licensor parent style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo panel rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo parent rdquo mean treebnt with office located floor parkview tower jungjail bundang seongnam gyeonggi republic korea style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo party rdquo ldquo party rdquo shall have meaning given such term preamble style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo patent rdquo shall mean nbsp patent patent application patent issuing such patent application well continuation division reissue examination foregoing style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo person rdquo shall mean individual sole proprietorship partnership limited partnership limited liability partnership corporation limited liability company business trust joint stock company trust unincorporated association joint venture other similar entity organization including government political subdivision department agency government style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo rdquo shall mean national institute health center disease control agency united state public health service within department health human service style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo license rdquo shall mean patent license agreement dated february between licensor attached hereto exhibit nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo product rdquo shall mean drug candidate that commonly identified drug drug candidate that contains derives from beta copy naturally occurring amino acid peptide regardless such beta rsquo origin chemical biological synthesis combination thereof product product part that covered whole part valid claim contained licensed patent term product shall include both clinical commercial application such product style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo product liability claim rdquo shall mean third party proceeding involving actual alleged death bodily injury arising resulting from product sold licensee sublicensees style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo prohibited list rdquo shall mean list excluded individual entity available through internet http general service administration rsquo list party excluded from federal program available through internet http epls debarment list available through internet http compliance_ref debar style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo prosecute rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo receiving party rdquo shall have meaning given such term section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo regulatory approval rdquo shall mean approval including extent necessary pricing approval license registration authorization governmental authority necessary promotion development including without limitation conduct clinical trial marketing distribution manufacture sale importation product style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text align left text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align left text indent ldquo regulatory authority rdquo shall mean applicable governmental authority jurisdiction territory from which regulatory approval required obtained style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent ldquo regulatory rdquo shall mean applicable governing nbsp marketing approval clearance import export testing investigation development manufacture packaging labeling handling storage distribution installation servicing marketing sale nbsp recordkeeping reporting obligation nbsp recall nbsp similar regulatory matter with respect product style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent ldquo relevant period rdquo shall mean product product basis country country basis period starting from effective date ending expiration last expire valid applicable licensed patent within given country territory twenty fifth anniversary first commercial sale each product such country whichever later style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo royalty term rdquo shall mean period commencing first commercial sale ending expiration effective date termination this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo sublicensee rdquo shall mean affiliate third party whom licensee sublicenses right permitted section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo sublicense rdquo shall mean consideration whatever form received from sublicensee connection with license sublicense right licensee affiliate hereunder including limited upfront received licensee affiliate granting license sublicense sublicensee payable upon occurrence milestone condition event happening which paid payable licensee affiliate from sublicensee periodic maintenance sublicense shall include amount paid purchase sublicensee debt equity security licensee other than extent which price paid such security exceeds their fair market value which case such excess shall deemed sublicense style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo beta rdquo shall mean amino acid peptide commonly referred thymosin beta style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo territory rdquo shall mean united state america style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo third party rdquo shall mean person other than licensor licensee affiliate either party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo trademark rdquo shall mean trademark trade dress brand mark trade name brand name logo business symbol other similar indicia origin style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent ldquo valid claim rdquo shall mean claim issued unexpired licensed patent that been revoked held unenforceable invalid decision court other governmental authority competent jurisdiction that appealable been appealed within time allowed appeal that been abandoned disclaimed denied admitted invalid unenforceable through reissue examination disclaimer otherwise style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent font style font time roman time serif section font license grant other right style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp license grant licensee style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp exclusive license develop subject term this agreement licensor hereby grant licensee exclusive irrevocable except otherwise provided this agreement license royalty free license licensed patent licensed know develop formulate product field territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp exclusive license make sell subject term this agreement licensor hereby grant licensee exclusive irrevocable except otherwise provided this agreement license royalty bearing license licensed patent licensed know manufacture distribute promote offer sell sell product field territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp early termination license subject term this agreement license granted licensee under this section shall terminate licensee begin either randomization dosing patient licensee sponsored clinical trial product neurotrophic keratopathy before first anniversary effective date syndrome before second anniversary effective date unless such delay commencement with regard neurotrophic keratopathy syndrome arose resulted from caused directive with regard requirement regulatory matter product such clinical trial style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp sublicensing style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensee shall entitled sublicense right granted licensee pursuant section affiliate third party upon thirty rsquo prior written notice licensor subject licensor rsquo written approval which approval shall unreasonably withheld which notice shall include identity such affiliate third party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp sublicenses granted affiliate third party pursuant section nbsp above shall subject term condition obligation covenant this agreement applicable provision license sublicense shall relieve licensee obligation hereunder style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp further license except license expressly granted licensee pursuant this agreement other right license granted licensee under this agreement implication style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensor rsquo retained right notwithstanding right granted licensee section without limiting generality section licensor retains right style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp conduct have conducted clinical trial other study involving product territory generation data support regulatory submission regulatory authority outside territory within territory outside field each case where exclusive license granted licensee section above style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp conduct activity territory with respect development manufacture formulation processing product commercialization outside country territory where exclusive license granted licensee section above style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp negative covenant licensee covenant that will will permit affiliate practice licensed patent licensed know outside scope license granted under this section style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp transfer licensed know upon reasonable request licensee cost licensee licensor shall promptly provide licensee with such tangible embodiment licensed know licensor rsquo possession control permit licensee enjoy license granted pursuant section above style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp affiliate each party rsquo option each party rsquo right under this agreement exercised affiliate such party further each party rsquo option each party rsquo obligation under this agreement performed affiliate such party such obligation will deemed satisfied upon performance such affiliate avoidance doubt nothing contained this section shall relieve each party obligation hereunder unless fully performed affiliate style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp reserved right notwithstanding anything contained section nbsp contrary licensee style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp acknowledges that retained certain right interest licensed patent pursuant license style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp agrees that provision license contained exhibit nbsp shall binding licensee successor licensee successor were licensee under license style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp shall assist licensor complying with licensor rsquo obligation under license style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent font style font time roman time serif section font development style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp development plan style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp development plan licensee will exercise commercially diligent effort carrying development activity with respect product territory accordance with development plan agreed upon from time time writing party ldquo development plan rdquo development plan attached this agreement exhibit incorporated reference herein style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp development activity purpose this agreement development activity shall mean activity that reasonably required obtain regulatory approval product territory treatment syndrome including without limitation toxicology vitro testing vivo testing silico testing stability testing statistical analysis report writing packaging regulatory affair preclinical study clinical trial style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp content development plan development plan amended after effective date shall include extent applicable identity product developed description program development such product through regulatory approval territory nbsp description development activity which shall include appropriate preclinical study pharmacology toxicology formulation clinical pharmacology study clinical study regulatory plan other element necessary obtain regulatory approval product specific plan protocol synopsis clinical study nbsp schedule such activity nbsp tentative deadline meeting regulatory milestone style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp update amendment development plan party shall amend development plan least once every twelve month expand refine description activity specified initial development plan other then current development plan other development activity anticipated schedule budget such activity such amended development plan shall become effective only upon approval joint development committee party fail update development plan required this section most recently approved development plan shall continue effect until such time amended development plan becomes effective style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp joint development committee within ninety following effective date parent licensor shall establish joint development committee ldquo joint development committee rdquo coordinate oversee development product territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp composition joint development committee joint development committee shall consist three person from parent from licensor each whom shall have relevant experience skill appropriate service joint development committee such having served head clinical manufacturing commercial development parent licensor establish later change number representative that parent licensor joint development committee parent licensor change representative joint development committee time upon notice parent case licensor licensor case parent style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp decision joint development committee except otherwise provided this agreement event that joint development committee reach decision matter properly before parent shall have final decision making authority with respect such matter including approval amendment development plan provided however that such matter under dispute shall first referred parent licensor rsquo respective president chief executive officer attempted resolution good faith negotiation within fourteen further provided that final decision made parent shall consistent with term this agreement including licensee rsquo diligence obligation hereunder adversely affect right obligation licensor licensee parent under this agreement material manner adversely affect development manufacture commercialization product material manner outside field outside territory reasonably determined either party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp activity joint development committee joint development committee shall responsible establishing approving development plan style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp meeting joint development committee joint development committee shall hold first meeting within ninety after effective date shall meet thereafter least once year territory schedule location mutually determined parent licensor joint development committee will convene least monthly teleconference periodically person discus agree development product territory share information relating thereto meeting joint development committee called either parent licensor upon reasonable advance notice other subject parent licensor rsquo mutual agreement regular meeting face face teleconference videoconference addition designated member joint development committee each licensor parent shall allowed have such other their respective representative attend meeting provided that only member joint development committee designated accordance with section above shall have voting right style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp joint development committee expense parent licensor shall respectively bear expense participation representative joint development committee joint development committee meeting style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp clinical trial licensee shall responsible conducting having conducted clinical trial product territory paying cost other expense associated therewith style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp regulatory approval licensee shall responsible obtaining maintaining regulatory approval necessary conduct such clinical study clinical trial other supporting study paying cost other expense associated therewith style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp licensor rsquo cooperation reasonably requested licensee licensor shall cooperate with assist licensee obtaining regulatory approval necessary conduct clinical trial commercialization product territory connection therewith licensor shall provide licensee upon request with copy regulatory material data reasonably necessary these purpose style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp diligence licensee shall time exert than commercially diligent effort develop product territory including seeking regulatory approval marketing approval product territory licensee shall require affiliate sublicensees third party develop product such effort licensee behalf without limiting generality foregoing licensee rsquo failure comply with section above shall constitute failure exert commercially diligent effort develop product territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp cooperation development party mutually acknowledge that subject other provision this agreement licensor licensee parent shall closely collaborate party reasonably agree development commercialization product global basis furtherance such collaboration party agree share clinical clinical data manufacturing process formulation data other information necessary development product which data shall constitute confidential information subject term condition section provide each other right make reference such data information each party rsquo respective effort develop product case licensee within field territory case licensor outside territory outside field territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent font style font time roman time serif section font commercialization product style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp commercialization plan style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp initial commercialization plan licensee shall provide licensor with plan commercialization product territory ldquo commercialization plan rdquo will carry commercialization activity with respect product territory initial commercialization plan shall provided licensor within hundred eighty prior date which first commercial sale within territory anticipated style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp commercialization activity purpose this agreement commercialization activity shall mean appropriate activity undertaken before after regulatory approval relating specifically marketing sale distribution product territory including without limitation sale force detailing advertising education planning marketing sale force training distribution scientific medical affair pricing related term product style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp content commercialization plan style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp description activity commercialization plan amended needed shall include reasonable description activity that licensee shall undertake order market product territory including limited medium marketing plan promotional activity similar matter including detailed budget identity intended major distributor sublicensees style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp sale target party acknowledge that effective date specific sale target marketing year difficult determine commercialization plan shall specify broad range sale target that will refined updated amendment commercialization plan product territory approach regulatory approval style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp amendment commercialization plan party shall amend commercialization plan least once every twelve month after first commercial sale refine description activity specified initial commercialization plan subsequently amended commercialization plan other commercialization activity update anticipated schedule budget such activity update sale target such amended commercialization plan shall comply with provision section nbsp party fail update commercialization plan required this section nbsp most recently approved commercialization plan shall continue effect until such time amended commercialization plan becomes effective pursuant this section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp diligence licensee shall time exert than commercially diligent effort promote market distribute least product territory licensee shall require affiliate sublicensees distributor other third party promote market distribute product such effort licensee behalf style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp notification benchmark milestone licensee shall report writing licensor date first commercial sale within territory achievement milestone specified this agreement within such occurrence style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent font style font time roman time serif section font royalty license style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp royalty style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp except otherwise provided section quarterly basis accordance with section licensee shall licensor royalty aggregate sale during royalty term rate style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notwithstanding section with respect sale syndrome indication quarterly basis accordance with section licensee shall licensor royalty aggregate sale made licensee affiliate during royalty term rate with respect such sale made affiliate licensee during royalty term royalty equal greater applicable royalty payable licensee royalty such aggregate sale made such affiliate licensee rate either case clause when received licensee style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp case generic branded generic product third party becomes commercially available within territory without direct indirect agreement with licensee affiliate their sublicensees distributor such generic branded generic taken aggregate have according similar data source market share term unit quantity territory least then royalty rsquo rate applicable payable licensee sale territory will reduced provided however that such generic branded generic taken aggregate have according similar data source market share least then royalty rsquo rate applicable payable licensee sale territory will reduced that such generic branded generic taken aggregate have according similar data source market share least then royalty rsquo rate applicable payable licensee sale territory will reduced style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp necessary licensee obtain license from third party under patent particular country territory order make sell product licensee obtains such license licensee deduct from royalty payment that would otherwise have been pursuant section with respect sale applicable product territory particular applicable quarterly period amount equal royalty paid licensee such third party pursuant such license account sale such product territory during such applicable quarterly period style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp each payment royalty required this section shall payable later than sixty after quarterly period ending june december which applicable sale were made style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp front other milestone payment percentage ownership adjustment style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensee shall licensor refundable five hundred thousand dollar within forty five business following effective date style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensee shall promptly licensor refundable five hundred thousand dollar upon earlier randomization dosing first patient either phase phase clinical trial evaluating product patient with syndrome phase clinical trial evaluating product patient with neurotrophic keratopathy clinical trial product shall satisfy milestone requiring payment under this section whether such clinical trial conducted behalf licensee affiliate sublicensee third party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp royalty report within thirty following each quarterly period during royalty term ending march june september december licensee shall deliver licensor complete detailed accurate written report corresponding quarerly period showing nbsp gross amount sale item item basis product licensee sublicensees distributor independent buyer whether user wholesaler otherwise bona fide rsquo length transaction nbsp adjustment resulting from deduction definition ldquo sale nbsp total sale nbsp conversion into united state dollar pursuant section nbsp such sale made another currency calculation royalty such report shall also reflect sublicense payable licensee during such quarterly period style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp manner payment payment licensor under this agreement shall payable united state dollar wire transfer immediately available fund such bank account licensor shall designate such other method licensor reasonably designate style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp exchange rate when converting amount another currency into united state dollar licensee shall exchange rate equal york foreign exchange rate quoted wall street journal business that five prior date payment under this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp interest late payment payment paid within thirty calendar from date such payment under this agreement shall subject interest from including date such payment through including date such payment actually made annual rate equal percent plus annual prime rate interest quoted money rate section nbsp wall street journal calculated daily basis year such rate available reason similar reputable data source lower highest rate permitted under applicable payment such interest shall limit licensor from exercising other right have consequence lateness payment style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp record audit right style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp record licensee shall maintain shall require affiliate sublicensees distributor maintain during term period five year thereafter complete detailed accurate book record connection with sale product necessary allow accurate determination financial accounting information relevant either party rsquo payment obligation hereunder including without limitation necessary calculation royalty licensor hereunder style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp audit right style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensor representative shall have right annually audit licensee rsquo affiliate rsquo sublicensees rsquo distributor rsquo record forth this section nbsp licensee shall permit licensor representative have access during normal business hour such record licensee affiliate sublicensees font style color font reasonably necessary verify accuracy royalty report hereunder marketing year ending more than five year prior date such request annual audit take place more often than once each calendar year notice licensor rsquo intent conduct audit must provided within thirty licensor rsquo receipt periodic royalty report reflecting full yearly sale product except otherwise provided section nbsp licensor shall responsible cost expense relating audit conducted under this section nbsp licensee shall cause affiliate sublicensees agree make their record available audit licensor representative forth this section nbsp font style color font style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp audit conducted licensor representative show underpayment royalty licensor licensee shall remit licensor amount such underpayment within thirty after receipt licensor rsquo request therefor underpayment royalty exceeds five percent total amount owed period then being audited licensee shall responsible promptly shall reimburse licensor licensor rsquo reasonable pocket cost conducting audit audit conducted licensor representative show overpayment royalty licensor such overpayment shall refunded licensee promptly style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp confidentiality licensor shall treat financial information licensee affiliate sublicensees distributor that licensor review connection with audit conducted under this section nbsp confidential information licensee subject provision section this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent font style font time roman time serif section font regulatory matter style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp regulatory approval licensee shall have sole authority responsibility obtain name maintain regulatory approval marketing approval with respect product territory licensor shall promptly after effective date provide licensee with material including limited regulatory progress report inds issued relevant local regulatory authority copy relevant data related product owned licensor that have been filed with only when licensee expressly prohibited from being sponsor clinical trial product conducted licensee applicable regulatory territory subject prevailing applicable regulatory territory licensor have right designated sponsor instead irrespective exercise such right licensee shall time responsible ensuring that clinical trial conducted compliance with applicable regulatory other requirement regulatory authority territory regulatory other requirement governmental authority including promulgated that would applicable such clinical trial were sponsored under licensor rsquo otherwise subject jurisdiction style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp contact with governmental authority subject other provision this section nbsp licensee shall solely responsible responding inquiry notice violation warning letter serious adverse event such term defined applicable guideline sect inspectional observation other action from governmental authority territory each case extent related product territory licensor licensee shall immediately forward each other copy material correspondence from governmental authority that receives respect product notwithstanding other provision this section nbsp licensee shall respond inquiry other correspondence from governmental authority with respect product territory without first providing licensor with copy proposed response incorporating reasonable comment licensor such response licensor shall cooperate with licensee responding inquiry other correspondence from governmental authority timely manner including promptly responding inquiry licensee relating thereto style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp regulatory information each party agrees provide other party with reasonable assistance take action reasonably requested other party that necessary desirable enable other party comply with other requirement governmental authority applicable product such assistance action shall include among other thing nbsp informing other party within five business receiving notice action notification other information which receives directly indirectly from governmental authority that raise material concern regarding safety efficacy product indicates suggests potential material liability either party third party arising connection with product reasonably likely lead field alert report recall market withdrawal product provided that neither party shall obliged disclose information breach contractual restriction nbsp licensee immediately reporting licensor occurrence adverse reaction including without limitation death other incident during clinical trial medicinal exam other information enable licensor fulfill reporting obligation governmental authority further specified safety agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp official documentation licensee shall provide licensor exact copy official registration importation document supplied relevant regulatory authority immediately upon issuance case early termination this agreement licensee shall provide licensor original version such registration document that otherwise licensor rsquo possession section style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp clinical trial report without limiting licensee rsquo obligation under this agreement licensee shall responsible preparing clinical trial yearly progress report clinical trial final report other report required regulatory authority connection with clinical trial product provided however that licensee shall provide draft such report licensor rsquo knowledge prior submission applicable regulatory authority provide final report submitted applicable regulatory authority with respect clinical trial product containing beta that directly related development product field territory that have been completed prior progress date hereof licensor shall provide licensee with copy related clinical trial report that licensor right disclose promptly upon execution hereof upon finalization report applicable style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp unknown side effect adverse reaction style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp reporting unknown side effect adverse reaction each party shall provide promptly other party information data relating serious previously unknown side effect adverse reaction relating product that providing party receives from source further specified safety agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp safety agreement promptly after effective date before date that licensee commences clinical trial product territory party shall enter into separate written safety agreement containing nbsp appropriate provision addressing safety issue relating product nbsp description type side effect reaction that must reported pursuant section nbsp other complaint information request that must reported such cooperative working procedure reasonably necessary ensure that satisfactory system process place ensure effective exchange safety other medical information relating product ldquo safety agreement rdquo style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent font style font time roman time serif section font intellectual property style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp trademark licensee shall free licensee rsquo trademark other trademark owned licensee territory product style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp ownership invention style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensee invention subject license granted licensor herein licensee shall invention know that invented developed conceived only employee consultant contractor licensee ldquo licensee invention rdquo licensee shall have written agreement place with employee consultant contractor giving licensee right authority necessary grant license section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensor invention subject license granted licensee herein licensor shall invention know that invented developed conceived only employee consultant contractor licensor ldquo licensor invention rdquo licensor shall have written agreement place with employee consultant contractor giving licensor right authority necessary grant license section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp joint invention licensee licensor shall jointly invention know that invented developed conceived employee consultant contractor both licensee licensor ldquo joint invention rdquo party will agree case case basis appropriate allocation cost control concerning matter regarding prosecution maintenance defense infringement patent such joint invention style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp license certain invention style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp license grant licensor extent that licensee invention joint invention relates development promotion marketing distribution manufacturing sale product licensee hereby grant licensor licensor hereby accepts additional consideration exclusive perpetual transferable sublicensable through multiple tier license under licensee rsquo right such licensee invention joint invention applicable research develop promote market distribute manufacture have manufactured sell offer sale import product outside territory outside field during term this agreement upon termination this agreement reason within territory within field foregoing license shall include right make reference transferable licensor affiliate sublicensees regulatory filing made licensee territory data information generated behalf licensee derived resulting from activity conducted behalf licensee pursuant this agreement including licensee product data development manufacture commercialization product outside territory outside field licensee shall promptly disclose licensee invention joint invention writing licensor licensor desire such licensee invention joint invention development manufacture commercialization product outside territory outside field licensor shall notify licensee writing style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp license grant licensee extent that licensor invention joint invention relates development promotion marketing distribution sale product then such licensor invention licensor rsquo interest such joint invention applicable shall deemed licensed patent shall subject license granted licensee pursuant section party shall promptly disclose other party invention that relevant product subject license granted hereunder style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp license parent extent that licensee invention joint invention relates development promotion marketing distribution manufacturing sale product licensee licensor each hereby grant parent parent hereby accepts additional consideration exclusive transferable sublicensable through multiple tier license under licensee rsquo right such licensee invention joint invention applicable research develop promote market distribute manufacture have manufactured sell offer sale import product within ldquo territory rdquo such term defined asia license agreement which license shall terminate such time asia license agreement terminates style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp patent marking licensee shall shall cause affiliate sublicensees distributor mark product sold otherwise distributed pursuant this agreement accordance with applicable patent statute other relevant regulation jurisdiction territory which such product manufactured sold otherwise distributed style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp prosecution maintenance licensed patent licensed licensee territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp prosecution between licensor licensee licensee shall have right obligation sole cost expense prepare file prosecute maintain licensed patent territory pursue proceeding including interference examination examination protest reissue opposition proceeding like relating licensed patent collectively ldquo prosecute rdquo territory such cost expense shall shared equally party party agree utilize licensor rsquo intellectual property counsel counsel shall promptly provide licensee with information related such prosecution event that licensee fails otherwise elect prosecute licensed patent shall provide rsquo advance notice thereof following such period licensor shall have right prosecute such licensed patent territory expense licensee rsquo license other right such licensed patent shall terminate style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp cooperation connection with licensee rsquo activity prosecute licensed patent licensor shall cooperate fully provide licensee with information assistance that licensee reasonably request including executing such document necessary with respect such prosecution activity licensor becomes aware patent information proceeding other matter that affect preparation filing prosecution maintenance licensed patent that adversely impact validity scope title enforceability licensed patent licensor shall promptly notify licensee such patent information proceeding matter style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp infringement third party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notice licensee learns actual possible infringement licensed patent territory actual possible misappropriation misuse licensed know licensee shall promptly notify licensor such infringement misappropriation misuse style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp right bring suit territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp between licensor licensee licensee shall have right obligation bring control legal action proceeding with respect infringement licensed patent misappropriation misuse licensed know third party territory expense using counsel choice which acceptable licensor reasonable discretion style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp event that licensee decline take legal action with respect infringement licensed patent licensor shall have right after giving licensee working rsquo prior notice intent take such legal action expense with concomitant right choose legal counsel reasonably acceptable licensor determine legal strategy licensee shall have right participate such legal action using counsel expense style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp action proceeding brought licensor pursuant this section nbsp licensor unable initiate prosecute such action solely name then licensee shall join such action voluntarily shall execute document necessary initiate litigation prosecute maintain such action style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp connection with action proceeding brought licensor pursuant this section nbsp licensee shall cooperate fully will provide licensor with information assistance that licensor reasonably request style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp certification each party shall inform other party certification related product regarding licensed patent receives pursuant either sect sect nbsp nbsp successor provision equivalent regulation jurisdiction territory shall provide other party with copy such certification within five nbsp receipt such party licensor rsquo licensee rsquo right with respect initiation prosecution legal action result such certification recovery obtained result such legal action shall forth this section style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp defense third party claim style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notice either party learns that third party commenced plan commence either claim counterclaim action declaratory judgment action proceeding challenging licensed patent jurisdiction territory such party shall promptly provide other party with notice thereof style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensor rsquo right defend between licensor licensee licensor shall have right obligation defend control claim counterclaim other action initiated third party challenging licensed patent jurisdiction territory each ldquo challenge rdquo expense using counsel choice style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp defense challenge pursuant this section nbsp licensor unable initiate prosecute such defense solely name then licensee subject necessary approval relevant court shall join such action voluntarily shall execute document necessary initiate litigation prosecute maintain such action style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp connection with defense challenge brought licensor pursuant this section nbsp licensee shall cooperate fully will provide licensor with information assistance that licensor reasonably request style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp award recovery recovery obtained either party connection with result action contemplated section nbsp whether settlement otherwise shall shared follows style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp such recovery shall first allocated party directing prosecution defense such action reimbursement respect respective pocket cost expense incurred connection therewith style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp remaining amount after such reimbursement shall split equally party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent font style font time roman time serif section font confidentiality press release style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp confidential information except extent expressly authorized this agreement otherwise agreed writing party party agree that receiving party ldquo receiving party rdquo shall keep confidential shall publish otherwise disclose purpose other than provided this agreement confidential information which disclosed other party affiliate thereof each ldquo disclosing party rdquo except extent that receiving party demonstrate competent written evidence that such confidential information style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp already legally possession receiving party other than under obligation confidentiality time disclosure disclosing party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp generally available public otherwise part public domain time disclosure receiving party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp became generally available public otherwise part public domain after disclosure other than through omission receiving party breach this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp disclosed receiving party other than under obligation confidentiality third party obligation disclosing party disclose such information others style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp independently discovered developed receiving party without confidential information provided disclosing party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp exception obligation this section shall apply confidential information that style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp submitted governmental authority receiving party facilitate issuance regulatory approval product obtain maintain enforce defend patent each case only extent permitted this agreement provided that such disclosure only extent reasonably necessary obtain regulatory approval patent applicable receiving party shall take reasonable measure assure confidential treatment such information extent applicable receiving party shall give business rsquo prior written notice disclosing party such disclosure confidential information including scope detail nature such confidential information style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp provided receiving party third party including case licensee affiliate sublicensees distributor under written confidentiality agreement having provision least stringent those this agreement consulting development external testing marketing trial other similar activity extent that such receiving party permitted conduct such activity pursuant this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp otherwise required disclosed receiving party compliance with including without limitation avoidance doubt requirement security exchange commission other stock exchange market which security issued party traded order court other governmental authority having competent jurisdiction provided however that receiving party shall first give written notice disclosing party order allow disclosing party opportunity seek confidential treatment confidential information confidential information that disclosed pursuant order court other governmental authority shall remain otherwise subject confidentiality provision this section party disclosing confidential information pursuant order court other governmental authority shall take reasonable step necessary including without limitation obtaining order confidentiality ensure continued confidential treatment such confidential information style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp disclosure licensor disclose certain confidential information licensee order comply with license such event such confidential information shall subject applicable confidentiality provision license style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp return confidential information upon expiration termination agreement within thirty after expiration termination this agreement each party shall destroy certify other party such destruction return requested other party confidential information provided other party except otherwise forth this agreement except that each party retain single copy confidential information confidential legal file sole purpose ascertaining ongoing right responsibility regarding confidential information defending enforcing legal right style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp written agreement receiving party shall have effect obtain written agreement from each employee consultant contractor have access confidential information disclosing party which agreement shall obligate such person similar obligation confidentiality assign receiving party know information invention conceived made reduced practice such person during course performing receiving party rsquo obligation under this agreement each party will notify other party promptly upon discovery unauthorized disclosure confidential information other party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp remedy each party shall entitled addition other right remedy have equity seek injunction without posting bond other security enjoining restraining other party from violation threatened violation this section style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp prior confidentiality agreement nothing contained this section intended supersede term condition confidential disclosure similar agreement between licensor hand parent affiliate other such agreement shall remain effect with respect disclosure made thereunder prior effective date style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp press release except required including without limitation avoidance doubt requirement security exchange commission american stock exchange korean stock exchange other stock exchange which security issued party traded governmental authority neither party shall make press release other public announcement relating this agreement transaction described herein without prior written consent other party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent font style font time roman time serif section font representation warranty covenant style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp licensor representation warranty covenant licensor hereby represents warrant covenant licensee follows style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp execution delivery performance licensor this agreement consummation transaction contemplated hereby within licensor rsquo corporate power have been duly authorized necessary corporate action part licensor this agreement constitutes legal valid binding obligation licensor enforceable against licensor accordance with term style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp execution delivery performance this agreement licensor will violate order governmental authority style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp except required permit sale exportation product into territory from time time during term execution delivery performance this agreement licensor will require licensor obtain permit authorization consent from governmental authority such execution delivery performance will result material breach give rise termination agreement contract which licensor party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensor right authority grant license granted section this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp best licensor rsquo knowledge without investigation inquiry issued licensed patent valid style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensor received written communication from third party alleging that licensor rsquo practice licensed patent infringes right such third party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensor affiliate their respective employee agent contractor consultant have never been nbsp debarred nbsp convicted crime which person debarred under section nbsp generic drug enforcement section nbsp similar foreign jurisdiction licensor affiliate their respective employee agent contractor consultant have never been nbsp threatened debarred nbsp indicted crime otherwise engaged conduct which person debarred under section nbsp generic drug enforcement similar other jurisdiction licensor shall promptly notify licensee upon learning such debarment conviction threat indictment style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp licensee representation warranty covenant licensee hereby represents warrant covenant licensor follows style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp execution delivery performance licensee this agreement consummation transaction contemplated hereby within licensee rsquo corporate power have been duly authorized necessary corporate action part licensee this agreement constitutes legal valid binding obligation licensee enforceable against licensee accordance with term style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensee will time properly registered licensed qualified have requisite power authority under organizational document accordance with territory develop including without limitation conduct clinical trial promote market distribute import export sell product territory conduct business perform obligation hereunder during term shall take action required necessary obtain keep current governmental license permit registration approval including without limitation regulatory approval that necessary advisable carry activity hereunder style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp execution delivery performance this agreement licensee will violate order governmental authority style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp except regulatory approval required permit sale importation product from time time into territory during term execution delivery performance this agreement licensee will require licensee obtain permit authorization consent from governmental authority such execution delivery performance will result material breach give rise termination agreement contract which licensee party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensee affiliate their respective employee agent contractor consultant have never been nbsp debarred nbsp convicted crime which person debarred under section nbsp generic drug enforcement section nbsp similar foreign jurisdiction licensee affiliate their respective employee agent contractor consultant have never been nbsp threatened debarred nbsp indicted crime otherwise engaged conduct which person debarred under section nbsp generic drug enforcement similar other jurisdiction licensee shall promptly notify licensor upon learning such debarment conviction threat indictment style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensee affiliate their respective employee agent contractor consultant shall person prohibited list connection with performance obligation activity under this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensee shall carry obligation activity under this agreement including development promotion marketing distribution sale product accordance with term hereof applicable regulatory subsidiary legislation thereunder style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp effective date licensee belief good faith that will have sufficient financial resource available carry have carried obligation activity contemplated under this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensee affiliate shall develop promote market distribute sell during term product field except authorized permitted agreed otherwise herein that utilizes otherwise contains beta derivative analog fragment thereof without licensor rsquo prior written approval style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp licensee shall reverse engineer otherwise deconstruct component part finished product purpose developing product that would compete with product field style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp disclaimer warranty except forth this agreement neither party give other warranty express implied regarding product licensed know licensed patent scope validity thereof other warranty including without limitation warranty merchantability fitness particular purpose infringement expressly disclaimed style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent font style font time roman time serif section font indemnification style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp indemnification licensor licensor shall defend indemnify hold harmless licensee affiliate their respective officer director employee agent from against loss liability claim damage penalty fine cost expense including reasonable legal other litigation cost regardless outcome collectively ldquo loss rdquo arising result breach representation warranty licensor provided section product liability claim mandatory voluntary recall product jurisdiction territory extent that such loss caused nbsp failure product provided licensor conform relevant specification therefor specified with clinical supply provided licensee nbsp willful negligence licensor manufacturer clinical supply relation product provided however that licensor shall have obligation under this section nbsp licensee affiliate sublicensees distributor been negligent whether testing storing handling otherwise dealing with product case such loss arise attributable breach this agreement licensee style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp indemnification licensee licensee shall defend indemnify hold harmless licensor affiliate their respective officer director employee agent from against loss arising result breach representation warranty licensee provided section third party claim extent that such loss caused licensee rsquo affiliate rsquo sublicensee rsquo distributor rsquo manufacture storage development promotion marketing distribution sale product provided however that licensee shall have obligation under this section licensor manufacturer have been negligent whether manufacturing testing storing handling otherwise dealing with product case said claim arise attributable breach this agreement licensor style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp procedure party seeking indemnification under this section ldquo indemnified party rdquo shall give prompt notice party against whom indemnity sought ldquo indemnifying party rdquo assertion commencement claim indemnification pursuant this section shall provide indemnifying party such information with respect thereto that indemnifying party reasonably request failure give such notice will relieve indemnifying party indemnification obligation hereunder only extent that indemnifying party suffered actual prejudice thereby indemnifying party shall assume control defense settlement such action suit proceeding expense indemnified party shall requested indemnifying party cooperate reasonable respect such defense indemnifying party rsquo expense subject following indemnified party will entitled expense participate such defense employ separate counsel such purpose long indemnifying party diligently defending action suit proceeding pursuant this section indemnifying party will liable under this section settlement effected without consent party shall enter into compromise settlement which commits other party take forbear take action without other party rsquo prior written consent style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp consequential damage neither licensor hand licensee parent other shall liable otherwise responsible other party hereto loss profit diminution value incidental indirect consequential special exemplary punitive damage that arise relate this agreement performance breach hereof otherwise whether contract tort strict liability otherwise provided that foregoing limitation shall apply party rsquo indemnification obligation pursuant section nbsp above grossly negligent willful misconduct party party rsquo breach confidentiality obligation pursuant section nbsp hereof style font time roman time serif margin text indent font style font variant small nbsp font style font time roman time serif margin text indent font style font variant small nbsp nbsp nbsp nbsp font insurance style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp general liability each party shall maintain when available comprehensive general liability insurance including blanket contractual liability insurance through term five year thereafter which insurance shall afford limit than each occurrence bodily injury liability personal injury liability product liability property damage liability contractual liability completed operation liability each party shall ensure that such insurance will include coverage defense cost style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp product liability each party shall maintain when available thereafter throughout term product liability insurance commercially standard term pharmaceutical manufacturing industry with reputable insurer amount than occurrence annual aggregate style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp certificate insurance each party will provide upon request when available other with certificate insurance evidencing above showing name issuing company policy number effective date expiration date limit liability each party shall cause insurance policy name other party hereto additional insured each party rsquo general liability insurance policy shall contain waiver subrogation right which that party rsquo insurer have against other party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin nbsp style font time roman time serif margin text indent font style font time roman time serif section font information reporting style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp licensee examine upon reasonable prior written request having been made licensor more than twice year book record account licensor licensee shall entitled receive reasonable information including management account operating statistic other business financial information which exist time request keep properly informed about business affair licensor relevant interest shareholder style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp licensor shall provide reasonable access licensee rsquo personnel upon reasonable notice during normal business hour more than twice year access such book record account other information relating licensor which exist time request necessary them review information provided licensee pursuant section style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp information document provided made available review licensee shall constitute confidential information shall protected accordingly provided under section above style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent font style font time roman time serif section font term termination style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp term rule post expiration this agreement shall enter into full force effect effective date provided under this section term this agreement ldquo term rdquo shall product product basis shall continue until expiration last expire valid applicable patent within patent right territory following twenty five year from first commercial sale each product territory whichever later style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp term rule post termination style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination cause event party affiliate party applicable breach material obligation under this agreement agreement asia license agreement ldquo breaching party rdquo breaching party give written notice breaching party specifying claimed particular such breach event such material breach cured within sixty following date such written notification without prejudice other right remedy available time breaching party breaching party shall have right thereafter terminate this agreement provided however that such breach incapable being cured then such termination effective immediately upon such written notice breaching party notwithstanding foregoing licensor shall have right terminate this agreement event licensee fails timely make payment required section this agreement such failure continues business following such written notice style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination governmental action either party terminate this agreement upon rsquo prior written notice event that governmental authority take action raise objection ldquo governmental action rdquo that prevents licensee period than hundred eighty from importing exporting purchasing selling product territory that effect making licensor rsquo manufacture product unlawful style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination licensor patent challenge licensor terminate this agreement entirety immediately upon written notice licensee licensee affiliate including parent sublicensees distributor directly indirectly individually association with person entity challenge validity enforceability scope licensed patent anywhere world style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination conversion pursuant license event that terminates license under article therein rescinds licensed field that term defined license that includes portion field which licensee licensed hereunder licensee option style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp terminate this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp convert this agreement license between licensee hand licensor other hand with such conversion subject approval which shall unreasonably withheld contingent upon licensee rsquo acceptance provision license font style color font style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination bankruptcy extent permitted under applicable time during term event bankruptcy defined below relating either party ldquo bankrupt party rdquo occurs other party ldquo other party rdquo shall have addition other legal equitable right remedy available hereunder option terminate this agreement upon sixty written notice bankrupt party agreed understood that other party elect terminate this agreement upon occurrence event bankruptcy except otherwise agreed with trustee receiver appointed manage affair bankrupt party other party shall continue make payment required under this agreement event bankruptcy occurred bankrupt party shall have right terminate license granted herein term ldquo event bankruptcy rdquo mean filing court agency pursuant statute regulation state country petition bankruptcy insolvency reorganization arrangement appointment receiver trustee bankrupt party asset proposing written agreement composition extension bankrupt party rsquo debt being served with involuntary petition against bankrupt party filed insolvency proceeding such petition shall dismissed within sixty after filing thereof proposing being party dissolution liquidation when insolvent making assignment benefit creditor without limitation bankrupt party rsquo right under this agreement shall include those right afforded sect united state bankruptcy code ldquo bankruptcy code rdquo successor thereto bankruptcy trustee bankrupt party debtor debtor possession reject this agreement under sect bankruptcy code other party elect retain right licensed from bankrupt party hereunder other supplementary agreement hereto duration this agreement avail itself right remedy full extent contemplated this agreement sect bankruptcy code other relevant style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp effect termination style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp event early termination this agreement reason right license granted licensee under this agreement shall terminate including right license with respect licensed patent licensed know licensee shall transfer licensor data file record information other material including clinical supply product including original registration importation document specified section nbsp possession control relating containing comprising product including licensor rsquo confidential information style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp transfer material event early termination this agreement reason style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp extent transferred pursuant section licensee shall provide licensor copy documentation data owned licensee tangible form time termination agreement that been generated with respect product necessary enable licensor continue development product commercialization thereof territory collectively ldquo licensee product data rdquo licensor such licensee product data discretion exclusive basis extent necessary enable licensor affiliate third party behalf licensor affiliate continue develop commercialize product territory style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp such termination occurs after product received regulatory approval licensee shall permitted under applicable promptly transfer deliver licensor original copy regulatory approval obtained connection with product territory including official registration license permit certificate importation document issued regulatory authority territory well regulatory documentation application regulatory approval submitted regulatory authority territory connection with product licensor shall licensee rsquo direct pocket cost compliance with this section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp extent that regulatory approval issued name licensee affiliate sublicensees other designee licensee shall extent permitted applicable promptly assign procure assignment licensor designee such regulatory approval event assignment permitted under applicable carried other reason licensee shall take step that necessary desirable assist licensor obtain such regulatory approval name licensor designee territory with such action including without limitation coordinating with applicable regulatory authority furnishing necessary information document respect thereof promptly cancelling terminating necessary regulatory approval held licensee affiliate sublicensee other designee which otherwise assignable transferable licensor designee licensor shall licensee rsquo direct pocket cost compliance with this section nbsp style font time roman time serif margin text indent font style font weight normal nbsp font style font time roman time serif margin text indent font style font weight normal nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font licensee shall assign cause affiliate assign licensor agreement with third party with respect conduct clinical trial product including agreement with contract research organization clinical site investigator unless expressly prohibited such agreement unless such agreement cover clinical trial product addition product which case licensee shall cooperate with licensor reasonable respect secure consent such third party such assignment conclusion agreement between licensor third party term substantially similar agreement between licensee third party licensor shall assume obligation under such agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp survival sublicenses sublicenses granted licensee sublicensees shall survive termination this agreement licensor shall assume such sublicenses licensor thereunder accordance with term such sublicenses provided however that licensor elect terminate such sublicenses licensor shall required under this section assume obligation under such sublicense that greater scope than those forth this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp remedy termination expiration termination this agreement either party shall affect claim demand liability right party arising pursuant this agreement prior such termination expiration hereof style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp survival following provision shall survive termination expiration this agreement section with respect sale made prior expiration termination this agreement provision license that binding licensee specified license surviving expiration termination thereof style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent font style font time roman time serif section font parent cooperation style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp cooperation parent acknowledges agrees that subject other provision this agreement will closely collaborate party reasonably agree development commercialization product global basis furtherance such collaboration parent agrees share know clinical clinical data manufacturing process formulation data other information necessary development product which data shall constitute confidential information subject term condition section addition each licensor licensee shall have right license such data information order utilize reference otherwise have benefit such data information support further development product including without limitation submission regulatory authority purpose obtaining regulatory approval otherwise case licensee within field territory case licensor outside territory within territory outside field during term this agreement field territory upon termination expiration this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp guaranty parent behalf itself successor assigns hereby unconditionally guarantee each every obligation licensee under this agreement agrees that shall jointly severally liable licensor with respect such licensee obligation hereunder style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent font style font time roman time serif section font miscellaneous style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp waiver waiver party breach provision this agreement shall operate construed waiver subsequent breach style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp modification change modification waiver term this agreement shall valid unless writing signed both party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp entire agreement this agreement including exhibit attachment hereto which incorporated herein reference constitutes entire agreement between party their affiliate with respect subject matter hereof thereof supersedes prior agreement understanding whether oral written between party except confidential disclosure agreement described section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp english language this agreement written executed english language translation into other language shall official version this agreement event conflict interpretation between english version such translation english version shall prevail style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp assignment except expressly permitted otherwise this agreement licensor licensee assign right delegate obligation hereunder person whether change control otherwise without first obtaining written consent other party which consent shall unreasonably withheld provided that either party without consent other party assign right delegate obligation hereunder affiliate upon thirty rsquo prior written notice other party sublicenses granted affiliate third party accordance with this agreement shall subject term condition obligation covenant this agreement applicable provision license such assignment shall remove mitigate obligation liability assigning party unless otherwise agreed writing assigning party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp independent contractor this agreement shall construed constituting partnership joint venture other form legal association that would impose liability upon party failure other party providing either party with right power authority express implied create duty obligation other party style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp third party beneficiary sublicense granted licensee affiliate third party pursuant section nbsp intended party third party beneficiary this agreement provided that such sublicense compliance with obligation under such sublicense extent that such obligation required under this agreement except expressly provided this section nbsp party intend will section this agreement interpreted create person third party beneficiary right style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp dispute dispute regarding scope validity enforceability patent excluded from this section nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp good faith negotiation officer event dispute between party arising relating this agreement breach termination other than termination convenience accordance with section invalidity thereof party seeking resolve such dispute will written notice other have such dispute referred their respective chief executive officer attempted resolution good faith negotiation within fourteen after such notice received style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp mediation event that party unable resolve dispute through good faith negotiation pursuant section party agree submit such dispute binding mediation using industry expert mutually acceptable party cost such mediation shall shared party equally style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp arbitration good faith attempt resolve dispute through negotiation mediation pursuant section have failed after sixty from notice provided pursuant section then upon request either party dispute shall finally resolved binding arbitration administered arbitration ldquo rule rdquo style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp arbitration shall conducted panel three neutral arbitrator ldquo panel rdquo appointed accordance with rule style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp arbitration proceeding shall take place york arbitral proceeding pleading shall english language style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp panel shall have power decide question arbitrability style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp request either party panel will enter appropriate protective order maintain confidentiality information produced exchanged course arbitration proceeding style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp panel empowered award remedy allowed including monetary damage prejudgment interest punitive damage grant final complete interim interlocutory relief including injunctive relief style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp party apply court competent jurisdiction within united state temporary restraining order preliminary injunction other interim conservatory relief necessary without breach this arbitration agreement without abridgment power arbitrator judgment award rendered panel entered court having jurisdiction thereof each party hereby waif defense have personal jurisdiction venue such court resolve such dispute including without limitation defense forum conveniens each party agrees file motion seek relief under forum conveniens defense style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp each party shall bear legal arising connection with dispute panel cost expense panel party manner panel deems appropriate under circumstance style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notice except otherwise provided herein notice other communication hereunder shall deemed sufficient given writing registered mail return receipt requested postage paid reputable high speed delivery service fedex courier addressed appropriate party address forth below such other place such party designate writing other party style font time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse margin left style vertical align style width font size text align justify licensor style width style font time roman time serif margin regenerx biopharmaceuticals style font time roman time serif margin shady grove road suite style font time roman time serif margin rockville maryland style font time roman time serif margin attn president style font time roman time serif margin phone style font time roman time serif margin style vertical align style font size text align justify nbsp style font size nbsp style vertical align style padding left font size text align justify text indent with copy style font time roman time serif margin text indent todd taylor style font time roman time serif margin fredrikson byron style font time roman time serif margin south street suite style font time roman time serif margin minneapolis minnesota direct style font time roman time serif margin table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse margin left style vertical align style width padding left font size text align justify text indent licensee style width style font time roman time serif margin regentree style font time roman time serif margin parkview tower style font time roman time serif margin jungjail bundang style font time roman time serif margin seongnam gyeonggi style font time roman time serif margin republic korea style font time roman time serif margin attn style font time roman time serif margin text indent phone style font time roman time serif margin text indent style font time roman time serif margin text indent nbsp style vertical align style font size text align justify with copy style font time roman time serif margin yoon yang style font time roman time serif margin asem tower style font time roman time serif margin yeongdongdaero gangnam style font time roman time serif margin seoul korea attn sung direct style font time roman time serif margin style font time roman time serif margin nbsp style vertical align style font size text align justify parent style font time roman time serif margin treebnt style font time roman time serif margin parkview tower style font time roman time serif margin jungjail bundang style font time roman time serif margin seongnam gyeonggi style font time roman time serif margin republic korea style font time roman time serif margin attn style font time roman time serif margin text indent phone style font time roman time serif margin style font time roman time serif margin nbsp style vertical align style font size text align justify with copy style font time roman time serif margin yoon yang style font time roman time serif margin asem tower style font time roman time serif margin yeongdongdaero gangnam style font time roman time serif margin seoul korea attn sung direct style font time roman time serif margin table style font time roman time serif margin text align left nbsp style font time roman time serif margin text align left such notice shall effective upon receipt style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp governing this agreement shall governed construed accordance with york without regard principle conflict party agree exclude application this agreement united nation convention contract international sale good style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp severability provision this agreement severable item provision this agreement shall extent invalid unenforceable remainder this agreement shall affected thereby each term provision this agreement shall valid shall enforced fullest extent permitted party will diligent good faith effort revise this agreement extent reasonably necessary effectuate their original intent purpose under this agreement style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align center text indent font style font variant small page font font style font variant small font signature appear following page style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text align center text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text indent witness whereof this agreement been executed duly authorized officer each party effective date style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style text indent nbsp colspan style text indent regenerx biopharmaceuticals style vertical align style width text indent nbsp style width text indent nbsp style width text indent nbsp style vertical align nbsp style border bottom black solid finkelstein style vertical align nbsp colspan name finkelstein style vertical align nbsp colspan title president style vertical align nbsp nbsp nbsp style vertical align nbsp colspan regentree style vertical align nbsp nbsp nbsp style vertical align nbsp style border bottom black solid yang style vertical align nbsp colspan name yang style vertical align nbsp colspan title president table style font time roman time serif margin nbsp style font time roman time serif margin text indent solely with respect obligation under section font style color blue font this agreement this agreement been duly executed acknowledged duly authorized officer parent effective date style font time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style text indent nbsp colspan style text indent treebnt style vertical align style width text indent nbsp style width text indent nbsp style width text indent nbsp style vertical align nbsp style border bottom black solid yang style vertical align nbsp colspan name yang style vertical align nbsp colspan title president table style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align center font style font variant small exhibit font style font time roman time serif margin text align center font style font variant small nbsp font style font time roman time serif margin text align left margin bottom exhibit nbsp ndash licensed patent style font time roman time serif margin text align left margin bottom exhibit nbsp ndash license term applicable licensee style font time roman time serif margin text align left margin bottom exhibit ndash development plan style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp font style font variant small nbsp font style font time roman time serif margin text align center font style font variant small exhibit font style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center licensed patent style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center summary ophthalmic patent patent application with relevant claim united state style font time roman time serif margin text align center nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif country font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom style font time roman time serif margin serial style font time roman time serif margin patent nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom style font time roman time serif margin priority date style font time roman time serif margin filing date nbsp nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif projected font font style font time roman time serif expiration font font style font time roman time serif date font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif status font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif independent claim font style vertical align nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style vertical align font style font time roman time serif font nbsp font style font time roman time serif united state font nbsp font style font time roman time serif font nbsp style font time roman time serif margin style font time roman time serif margin nbsp font style font time roman time serif font nbsp font style font time roman time serif issued font nbsp style font time roman time serif margin composition comprising polypeptide comprising amino acid sequence lkktet conservative variant thereof composition further comprising carrier application surface human body wherein said carrier application external surface said body internal surface said body composition comprising cream paste lotion spray suspension dispersion salve hydrogel ointment wherein said polypeptide gelsolin vitamin binding protein profilin cofilin depactin dnasei villin fragmin severin capping protein beta actinin acumentin wherein said polypeptide concentration said carrier least about about microgram microliter style font time roman time serif margin nbsp style font time roman time serif margin composition comprising polypeptide agent consisting essentially composition further comprising carrier application surface human body wherein said carrier application external surface said body internal surface said body composition comprising cream paste lotion spray suspension dispersion salve hydrogel ointment wherein said polypeptide concentration said carrier least about about microgram microliter table style font time roman time serif margin nbsp style font time roman time serif margin field rule page align left style margin margin bottom style font size border black solid width nbsp field rule page style font time roman time serif margin style font time roman time serif margin style font time roman time serif margin font style font family time roman time serif expiration date patent calculated with certainty until after issuance date marked with asterisk date calculated pending application estimated date which change potential patent term extension potential effect more terminal disclaimer other reason expiration date foreign country generally twenty year from filing date international application which they based always calculated this manner subject change font style font time roman time serif margin font style font variant small nbsp font style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence option newsection value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif country font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom style font time roman time serif margin serial style font time roman time serif margin patent nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom style font time roman time serif margin priority date style font time roman time serif margin filing date nbsp nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif projected font font style font time roman time serif expiration font font style font time roman time serif date font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif status font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif independent claim font style vertical align nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style vertical align font style font time roman time serif font nbsp font style font time roman time serif united state font nbsp font style font time roman time serif font nbsp style font time roman time serif margin style font time roman time serif margin nbsp font style font time roman time serif font nbsp font style font time roman time serif issued font nbsp style font time roman time serif margin method treating elevated intraocular pressure subject having elevated intraocular pressure comprising administering subject ophthalmically acceptable composition comprising peptide agent comprising amino acid sequence lkktet thymosin beta beta style font time roman time serif margin nbsp style vertical align font style font time roman time serif font nbsp font style font time roman time serif united state font nbsp font style font time roman time serif font nbsp style font time roman time serif margin style font time roman time serif margin nbsp font style font time roman time serif font nbsp font style font time roman time serif pending font nbsp style font time roman time serif margin method providing desired concentration administered thymosin beta body portion live human patient need thereof predetermined time which comprises style font time roman time serif margin nbsp style font time roman time serif margin determining thymosin beta treatment dosage using formula style font time roman time serif margin nbsp style font time roman time serif margin bull formula style font time roman time serif margin nbsp style font time roman time serif margin wherein predetermined concentration time dosage thymosin beta administered said live human patient time elapsed after administration dosage hour about about about about style font time roman time serif margin nbsp style font time roman time serif margin administering said dosage thymosin beta said live human patient achieve said desired concentration administered thymosin beta said body portion style font time roman time serif margin nbsp style font time roman time serif margin method providing desired concentration administered thymosin beta body portion live human patient need thereof predetermined time which comprises style font time roman time serif margin nbsp style font time roman time serif margin determining time administering thymosin beta treatment dosage using formula table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif country font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom style font time roman time serif margin serial style font time roman time serif margin patent nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom style font time roman time serif margin priority date style font time roman time serif margin filing date nbsp nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif projected font font style font time roman time serif expiration font font style font time roman time serif date font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif status font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif independent claim font style vertical align nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style vertical align nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font time roman time serif margin bull formula style font time roman time serif margin nbsp style font time roman time serif margin wherein predetermined concentration time dosage thymosin beta administered said live human patient time elapsed after administration dosage hour about about about about style font time roman time serif margin nbsp style font time roman time serif margin administering said dosage thymosin beta said live human patient achieve said desired concentration administered thymosin beta said body portion style font time roman time serif margin nbsp style font time roman time serif margin method maintaining concentration within efficient concentration range body portion live human patient need thereof over time comprising style font time roman time serif margin nbsp style font time roman time serif margin text indent nbsp nbsp selecting target concentration said body portion style font time roman time serif margin text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font time roman time serif margin maintaining said concentration within said efficient concentration range administering said live human patient calculating dosage amount administered time which said dosage amount administered according formula style font time roman time serif margin nbsp style font time roman time serif margin bull formula style font time roman time serif margin nbsp style font time roman time serif margin wherein target concentration wherein treatment dosage said live human patient wherein time elapsed after initial administration said live human patient hour wherein about about wherein about about style font time roman time serif margin nbsp style font time roman time serif margin administering said treatment dosage said live human patient time achieve said target concentration administered table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif country font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom style font time roman time serif margin serial style font time roman time serif margin patent nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom style font time roman time serif margin priority date style font time roman time serif margin filing date nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif projected font font style font time roman time serif expiration font font style font time roman time serif date font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif status font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif independent claim font style vertical align nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style vertical align nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font time roman time serif margin repeating maintain concentration said body portion within plusmn said target concentration style font time roman time serif margin nbsp style font time roman time serif margin method treatment provide desired concentration range body portion live human patient need thereof over period time while minimizing total amount which administered over said period time which comprises style font time roman time serif margin nbsp style font time roman time serif margin selecting desired concentration achieved said live human patient style font time roman time serif margin nbsp style font time roman time serif margin calculating dosage amount administered said live human patient using formula style font time roman time serif margin nbsp style font time roman time serif margin bull formula style font time roman time serif margin nbsp style font time roman time serif margin wherein said desired concentration said treatment dosage said live human patient about hour about about about about style font time roman time serif margin nbsp style font time roman time serif margin calculating total amount that administered daily style font time roman time serif margin nbsp style font time roman time serif margin calculating dosage amount administered said live human patient using formula style font time roman time serif margin nbsp style font time roman time serif margin bull formula style font time roman time serif margin nbsp style font time roman time serif margin wherein said desired concentration said treatment dosage said live human patient other than about hour about about about about style font time roman time serif margin nbsp style font time roman time serif margin calculating total amount that administered daily table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif country font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom style font time roman time serif margin serial style font time roman time serif margin patent nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom style font time roman time serif margin priority date style font time roman time serif margin filing date nbsp nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif projected font font style font time roman time serif expiration font font style font time roman time serif date font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif status font nowrap style width text align left vertical align bottom nbsp nowrap style width border bottom black solid text align left vertical align bottom font style font time roman time serif independent claim font style vertical align nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style vertical align nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font time roman time serif margin determining whether total amount administered lower style font time roman time serif margin nbsp style font time roman time serif margin administering said live human patient dosage amount time which result said lower total amount administered said live human patient style vertical align nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style vertical align font style font time roman time serif font nbsp font style font time roman time serif united state font nbsp font style font time roman time serif font nbsp style font time roman time serif margin style font time roman time serif margin nbsp font style font time roman time serif font nbsp font style font time roman time serif pending font nbsp style font time roman time serif margin method treating syndrome subject suffering from syndrome comprising administering subject ophthalmically acceptable composition twice more wherein said composition about comprises isolated peptide agent comprising amino acid sequence lkktet thymosin beta beta wherein said peptide agent present said aqueous medium concentration within range about ndash style font time roman time serif margin nbsp style font time roman time serif margin method treating syndrome subject suffering from syndrome comprising administering subject ophthalmically acceptable composition twice more wherein said composition comprises isolated peptide agent comprising amino acid sequence lkktet thymosin beta beta wherein said ophthalmically acceptable composition about wherein said peptide agent present said aqueous medium concentration within range about ndash style font time roman time serif margin nbsp style font time roman time serif margin method treating syndrome subject suffering from syndrome comprising administering subject ophthalmically acceptable composition twice more wherein said composition comprises isolated peptide agent comprising thymosin beta beta wherein said ophthalmically acceptable composition about wherein said beta present concentration within range about ndash style font time roman time serif margin nbsp table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text align center nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align center font style font variant small exhibit nbsp font style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center license term style font time roman time serif margin text align center applicable licensee style font time roman time serif margin nbsp style font time roman time serif margin term bold have meaning given such term license style font time roman time serif margin nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left reserve behalf government irrevocable nonexclusive transferable royalty free license practice invention licensed under licensed patent right throughout world behalf government behalf foreign government international organization pursuant existing future treaty agreement which government signatory prior first commercial sale licensee agrees provide reasonable quantity licensed product material made through licensed process solely research purpose commercial development manufacture distribution price equal licensee rsquo cost such table style font time roman time serif margin text indent nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left licensee agrees that product used sold united state embodying licensed product produced through licensed process shall manufactured substantially united state unless written waiver obtained advance from table style font time roman time serif margin text indent nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left licensee acknowledges that enter into future cooperative research development agreement cradas under federal technology transfer that relate subject matter this agreement agrees notify licensee soon practical proposed crada that relates subject matter this agreement licensee agrees unreasonably deny request research license from such future collaborator with when acquiring such right necessary order make cooperative research development agreement crada project feasible effective date this agreement licensee request that licensee have opportunity join party proposed cooperative research development agreement crada table style font time roman time serif margin text indent nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left addition reserved license paragraph above reserve right grant such nonexclusive research license directly require licensee grant nonexclusive research license commercially reasonable term purpose this research license encourage basic research whether conducted academic corporate facility order safeguard licensed patent right however shall consult with licensee before granting commercial entity research license providing them research sample licensed product material made through licensed process provided however that will provide material obtained from licensee under paragraph above third party except with licensee rsquo prior written consent which shall unreasonably withheld table style font time roman time serif margin text indent nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left licensee agrees keep accurate correct record licensed product made used sold imported licensed process practiced under this agreement appropriate determine amount royalty such record shall retained least five year following given reporting period shall available during normal business hour upon five business prior written notice from licensee inspection expense accountant other designated auditor selected sole purpose verifying report payment hereunder accountant auditor shall only disclose information relating accuracy report payment made under this agreement inspection show under reporting underpayment excess five percent twelve month period then licensee shall reimburse cost inspection time licensee unreported royalty including late charge required paragraph this agreement payment required under this paragraph shall within thirty date provides licensee notice payment table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence option newsection value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left licensee shall reasonable best effort bring licensed product licensed process practical application ldquo reasonable best effort rdquo purpose this provision shall include substantial adherence commercial development plan appendix substantial performance benchmark appendix amended from time time mutual written consent effort sublicensees affiliate shall considered effort licensee extent that benchmark development obligation forth appendix differ from conflict with those forth commercial development plan appendix appendix shall considered supersede appendix commercial development plan appendix shall amended consistent with appendix table style font time roman time serif margin text indent nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left upon first commercial sale until expiration this agreement licensee shall reasonable best effort make licensed product licensed process reasonably accessible united state public table style font time roman time serif margin text indent nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left licensee shall indemnify hold employee student fellow agent consultant ldquo indemnified party rdquo harmless from against liability demand damage expense loss including limited death personal injury illness property damage ldquo indemnified loss rdquo suffered indemnified party connection with arising behalf licensee sublicensees director employee third party licensed patent right nbsp design manufacture distribution licensed product licensed process material licensee other product process developed connection with arising licensed patent right licensee agrees maintain liability insurance program consistent with sound business practice notwithstanding other provision contrary licensee shall have obligation indemnify indemnified party from indemnified loss connection with arising design manufacture distribution licensed product licensed process behalf indemnified party table style font time roman time serif margin text indent nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left shall specifically have right terminate with licensee rsquo consent modify option this agreement determines that licensee nbsp using reasonable best effort effectuate commercial development plan submitted with request license licensee otherwise demonstrate rsquo satisfaction that licensee taken expected take within reasonable time effective step achieve practical application licensed product licensed process nbsp used reasonable best effort achieve benchmark modified under paragraph nbsp willfully made false statement willfully omitted material fact license application report required this agreement nbsp committed material breach covenant agreement contained license nbsp keeping licensed product licensed process reasonably available public after commercial commences nbsp reasonably satisfy unmet health safety need nbsp reasonably justify failure comply with domestic production requirement paragraph unless waived making this determination will take into account normal course commercial development program conduct with sound reasonable business practice judgment annual report submitted licensee under paragraph prior invoking this right shall give written notice licensee providing licensee specific notice ninety opportunity respond rsquo concern previous item licensee fails alleviate rsquo concern previous item fails initiate corrective action rsquo reasonable satisfaction terminate this agreement table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left reserve right according sect nbsp terminate modify this agreement determined that such action necessary meet requirement public specified federal regulation issued after date license such requirement reasonably satisfied licensee table style font time roman time serif margin text indent nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left within thirty receipt written notice rsquo unilateral decision modify terminate this agreement licensee consistent with provision appeal decision written submission designated official decision designated official shall final agency decision licensee thereafter exercise administrative judicial remedy that available table style font time roman time serif margin text indent nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align style width style width text align left within ninety expiration termination this agreement under this article final report shall submitted licensee royalty payment including those incurred paid such full minimum annual royalty those related patent expense shall become immediately payable upon termination expiration terminated under this article sublicensees elect convert their sublicenses direct license with licensee pursuant paragraph table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align center text indent font style font variant small exhibit font style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin text align center text indent development plan subject change style font time roman time serif margin text align center text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width font style font wingdings font style text align justify development plan treatment syndrome table style font time roman time serif margin nbsp style font time roman time serif margin type preind meeting with held april discus sponsor rsquo development plan font style font family time roman time serif beta font treatment corneal injury wound style font time roman time serif margin nbsp style font time roman time serif margin expected regulatory path considered preind meeting optional clinical study prenda meeting submission approval style font time roman time serif margin nbsp style font time roman time serif margin preind meeting style font time roman time serif margin preind meeting with being planned discus clinical study design requirement prior initiating optional clinical study which being planned from study design among alternative shall selected based upon comment during preind meeting risk feasibility assessment result with regulatory clinical expert style font time roman time serif margin nbsp style font time roman time serif margin optional clinical study style font time roman time serif margin alternative clinical study design such option option option option being planned from each optional study design consists phase study with relevant patient treatment style font time roman time serif margin nbsp style font time roman time serif margin radic option style font time roman time serif margin small phase patient style font time roman time serif margin large phase patient style font time roman time serif margin nbsp style font time roman time serif margin radic option style font time roman time serif margin large phase patient style font time roman time serif margin small phase patent style font time roman time serif margin nbsp style font time roman time serif margin radic option style font time roman time serif margin adaptive design phase patient style font time roman time serif margin nbsp style font time roman time serif margin radic option style font time roman time serif margin large phase patent style font time roman time serif margin korean phase patient style font time roman time serif margin nbsp style font time roman time serif margin prenda meeting style font time roman time serif margin meeting with being planned prior submission style font time roman time serif margin nbsp style font time roman time serif margin submission style font time roman time serif margin submission being planned style font time roman time serif margin nbsp field page sequence option newsection value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin approval style font time roman time serif margin approval expected style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width font style font wingdings font style text align justify development plan treatment neurotrophic keratopathy table style font time roman time serif margin nbsp style font time roman time serif margin type meeting with held september discus planned phase clinical nonclinical development font style font family time roman time serif beta font treatment neurotrophic keratopathy style font time roman time serif margin nbsp style font time roman time serif margin expected regulatory path considered type meeting phase clinical study prenda meeting submission approval style font time roman time serif margin nbsp style font time roman time serif margin type meeting style font time roman time serif margin type meeting with being planned discus pending issue which were discussed with prior initiating phase study contract manufacturing organization clinical trial material manufacturer selected based upon risk assessment result which planning with regulatory expert style font time roman time serif margin nbsp style font time roman time serif margin phase clinical study style font time roman time serif margin subject enrollment planned patient with study duration expected approximately week treatment follow period considered week week each primary endpoint being considered that percentage patient achieving complete healing persistent epithelial defect determined corneal fluorescein staining week considering nature orphan indication limited patient population site feasibility assessment successful patient recruitment initiated purpose initiating phase study style font time roman time serif margin nbsp style font time roman time serif margin prenda meeting style font time roman time serif margin meeting with being planned prior submission style font time roman time serif margin nbsp style font time roman time serif margin submission style font time roman time serif margin submission being planned style font time roman time serif margin nbsp style font time roman time serif margin approval style font time roman time serif margin approval expected style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent information marked been omitted pursuant request confidential treatment omitted portion been separately filed with security exchange commission style font time roman time serif margin text indent nbsp field page sequence option last style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table field page style font time roman time serif margin body html text document